Waun Ki Hong, MD, Oral History Interview, October 16, 2013
Files
Download Full Interview Transcript (335 KB)
Loading...
Description
Major Topics Covered:
- Personal and educational background; military experience
- Research: organ preservation (especially of the larynx), studies of leukoplakias, Vitamin A, chemoprevention, and personalized, targeted therapy; multi-disciplinary approaches to diseases of the aero-digestive system
- Approaches to research design, team science, translational research
- The Department of Thoracic and Head and Neck Medical Oncology: organization, fellowship program, creating an environment for excellence
- The Division of Cancer Medicine
- MD Anderson growth; the presidents
- Leadership; leading teams, fostering collaboration
Publication Date
10-16-2013
Publisher
The Historical Resources Center, Research Medical Library, The University of Texas Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Hong, Waun Ki MD and Rosolowski, Tacey A. PhD, "Waun Ki Hong, MD, Oral History Interview, October 16, 2013" (2013). Interview Sessions. 149.
https://openworks.mdanderson.org/mchv_interviewsessions/149
Conditions Governing Access
Open
About the Interview
About the Interview Subject:
Medical oncologist Waun Ki Hong, MD (b. 13 August 1942, Cheung Pyung [near Seoul], Republic of Korea) came to MD Anderson in 1984 as a full professor to serve as Chief of the Section of Head and Neck Medical Oncology. Dr. Hong’s research has had a translational focus, beginning with his studies of Vitamin A derivatives and publication of the first demonstration that a chemical product could reverse the course of cancer. He specializes in head/neck and lung cancers, with research focus in the areas of molecular therapeutics, cancer prevention, organ preservation, and personalized targeted therapy.
Dr. Hong he chaired the Department of Thoracic/Head and Neck Medical Oncology from 1993 until August 2013. Since 2001 he has served as Head of the Division of Cancer Medicine. Shortly after the completion of these interview sessions, he was named to the National Academy of Science.